Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Cora N. Sternberg
Based on 77 articles published since 2008
||||
Expertise Level
The expertise of Cora N. Sternberg ranks in the
  • Top 0.036%
  • ... of 129,687 published authors worldwide on Prostatic Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 77 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Sternberg, C N   ·   Sternberg, Cora N   ·   Sternberg, Cora
Work Locations
Details
Most likely:    San Camillo-Foranini Hospitals      
2018
  • Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy. · Radboud University Medical Centre, Nijmegen, Netherlands. · Amgen (Europe) GmbH, Zug, Switzerland. · Service d'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. Electronic address: · Pubmed 29787892
  • Robert H. Lurie Comprehensive Cancer Center, Chicago, IL · University of Montreal Hospital Center, Montreal, QC, Canada · San Camillo Forlanini Hospital, Rome, Italy · Pubmed 30281993
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · National Cancer Institute, Vilnius, Lithuania. · Department of Oncology, Herlev Hospital, Herlev. · Department of Oncology, Aalborg University Hospital, Aalborg, Denmark. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon. · INSERM, UMR1098, Besançon. · Medicine, Centre Léon Bérard, Lyon, France. · Department of Oncology & Hematology, Azienda University Hospital, Modena, Italy. · Dana-Farber/Brigham and Women's Cancer Center, Boston, USA. · Department of Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Department of General Medical Oncology, University Hospitals Leuven, Leuven. · KU Leuven, Leuven, Belgium. · Urocentrum, Prague, Czech Republic. · General Oncology Department, Centre Oscar Lambret, Lille, France. · Lithuanian University of Health Sciences Hospital, Kaunas, Lithuania. · Gabinet Urologiczny, Gdynia, Gdansk, Poland. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Ipsen Innovation, Les Ulis, France. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Pubmed 29059273
  • OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Electronic address: · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Cancer Medicine, Gustave Roussy, University of Paris-Sud, Villejuif, France. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium. · Department of Medical Oncology, Vall d'Hebron University Hospital, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medicine, University of Colorado School of Medicine, Aurora, CO. · Department of Medical Oncology, USC Norris Cancer Hospital, Keck Medical Center of USC, Los Angeles, CA. · Department of Biostatistics, Astellas Pharma Europe, BV, Leiden, Netherlands. · Department of Biostatistics, Medivation, Inc, San Francisco, CA. · Department of Clinical Development, Medivation, Inc, San Francisco, CA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 28344102
  • Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands. · US Oncology Research, Houston, Texas3Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Yale Cancer Center, Division of Oncology, Department of Medicine, New Haven, Connecticut. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin. · University Hospital del Mar-IMIM, Barcelona, Spain10Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · US Oncology Research, Houston, Texas11Rocky Mountain Cancer Centers, Aurora, Colorado. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, England. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare " Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, England. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, New Jersey. · Pubmed 27560549
  • US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. Electronic address: · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA. · Oncology Hematology Care, Inc., Cincinnati, OH, USA. · US Oncology, Cancer Centers of North Carolina, Raleigh, NC, USA. · Texas Oncology, Austin, TX, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Department of Uro-Oncology, Centrum Onkologii - Instytut im Marii Sklodowskiej-Curie, Warsaw, Poland. · Celgene Corporation, Summit, NJ, USA. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. · Pubmed 27522164
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Clinical Medicine, Rigshospitalet, Copenhagen, Denmark. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Medical Oncology, Astellas Pharma, Inc., Northbrook, IL, USA. · Biostatistics, Astellas Pharma, Inc., Northbrook, IL, USA. · Pubmed 28117385
2016
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Padiglione Flajani, Circonvallazione Gianicolense 87, Rome, 00152, Italy. Electronic address: · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Padiglione Flajani, Circonvallazione Gianicolense 87, Rome, 00152, Italy. Electronic address: · Pubmed 27637350
  • Department of Molecular and Translational Medicine, University of Brescia, 25123, Brescia, Italy; Molecular Therapy and Pharmacogenomic Unit, ASST di Cremona, Viale Concordia 1, 26100, Cremona, Italy. Electronic address: · Department of Molecular and Translational Medicine, University of Brescia, 25123, Brescia, Italy. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Radiotherapy Department, Azienda Ospedaliera "Istituti Ospitalieri di Cremona", Cremona, Italy. · Molecular Therapy and Pharmacogenomic Unit, ASST di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Medical Oncology Department, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Pathology, Peter Mac Callum Cancer Centre, and Department of Pathology, University of Melbourne, Australia. · Molecular Therapy and Pharmacogenomic Unit, ASST di Cremona, Viale Concordia 1, 26100, Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, 34129, Trieste, Italy. · Pubmed 27162152
  • Matthew Smith, Massachusetts General Hospital, Boston, MA · Johann De Bono, Royal Marsden Hospital, Sutton · Syed Hussain, University of Liverpool, Liverpool, United Kingdom · Cora Sternberg, San Camillo and Forlanini Hospitals, Rome · Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola · Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy · Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce · Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris · Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon · Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes · Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France · Michael Krainer, Medical University of Vienna, Vienna, Austria · Andries Bergman, Netherlands Cancer Institute, Amsterdam · Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands · Wolfgang Hoelzer, Praxis für Urologie · Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin · Martin Bögemann, University of Muenster Medical Center, Muenster · Susan Feyerabend, Studienpraxis Urologie, Nürtingen · Arnulf Stenzl, University Hospital, Tübingen, Germany · Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada · Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO · Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego · David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA · and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
  • Cora Sternberg, San Camillo Forlanini Hospitals, Rome, Italy · Andrew Armstrong, Duke Cancer Institute, Duke University, Durham, NC · Roberto Pili, Indiana University School of Medicine, Indianapolis, IN · Siobhan Ng, St John of God Medical Centre, Subiaco, Western Australia, Australia · Robert Huddart, Royal Marsden Hospital, Sutton · Nicholas James, Queen Elizabeth Hospital, Birmingham · Simon Chowdhury, Guy's Hospital and Sarah Cannon Research UK, London, United Kingdom · Neeraj Agarwal, University of Utah, Salt Lake City, UT · Denis Khvorostenko, Leningrad Regional Oncology Dispensary, St Petersburg, Russia · Olexiy Lyulko, Zaporizhzhya Regional Clinical Hospital, Zaporizhzhya, Ukraine · Arija Brize, Riga Eastern Clinical University Hospital, Riga, Latvia · Nicholas Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Rémy Delva, Centre Régional de Lutte Contre le Cancer Paul Papin, Angers · Jean-Christophe Pouget and Frédérique Baton, Ipsen Innovation, Les Ulis, France · Mihai Harza, Fundeni Clinical Institute, Bucharest, Romania · Anastasios Thanos, Agios Savas Anticancer Oncology Hospital of Athens, Athens, Greece · Patrick Werbrouck, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium · Martin Bögemann, Universitätsklinikum Münster, Münster, Germany · Thomas Hutson, Texas Oncology, Dallas, TX · Piotr Milecki, Poznan University of Medical Sciences, Poznan, Poland · Enrique Gallardo, Corporació Sanitaria Parc Taulí, Sabadell, Spain · Gilberto Schwartsmann, Hospital De Clinicas De Porto Alegre, Porto Alegre, Brazil · Thore Nederman and Helen Tuvesson, Active Biotech, Lund, Sweden · and Michael Carducci, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD. · Pubmed 27298414
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland Division of Oncology, Portland VA Medical Center, Portland, USA · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Divisions of Medical Oncology and Urology, Duke University Medical Center and the Duke Cancer Institute, Durham. · Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, USA. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, København, Denmark. · Department of Medical Oncology, University of Colorado Cancer Center, Aurora. · Medivation, Inc., San Francisco, USA. · Astellas Pharma Global Development, Inc., Leiden, The Netherlands. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 26578735
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Pubmed 27302137
  • Department of Medical Physics, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Department of Nuclear Medicine, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Health Physics Postgraduate School, "Sapienza" University of Rome, Piazzale Aldo Moro No. 5, 00185, Rome, Italy. · Department of Radiology, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Health Physics Postgraduate School, "Sapienza" University of Rome, Piazzale Aldo Moro No. 5, 00185, Rome, Italy. · Department of Radiological, Oncological and Anatomo Pathological Sciences, "Sapienza" University of Rome, Viale Del Policlinico No. 155, 00161, Rome, Italy. · Department of Medical Oncology, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Department of Medical Oncology, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Department of Nuclear Medicine, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Pubmed 26613714
  • Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 26659397
2015
  • Medical Oncology Department, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Medical Oncology Department, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 26170619
  • European School of Oncology, Milan, Italy; Prostate Cancer Programme, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Dept of Urology, University Hospital of the Katholieke Universiteit Leuven, Leuven, Belgium. · Renal Cancer Services, Royal Free Hospital, London, UK. · Dept of Urology, Heinrich Heine University Hospital, Düsseldorf, Germany. · Centre Polidisciplinaire d'Oncologie, Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Dept of Radiation Oncology, Institut Gustave Roussy, Villejuif, France. · Dept of Urology, Ausl Modena, Nuovo Ospedale Civile-S. Agostino Estense, Modena, Italy. · Europa Uomo, Antwerp, Belgium; Oncological Centre, Antwerp, Belgium. · King's College Hospital NHS Foundation Trust, London, UK. · University of Warwick, Cancer Research Unit, Coventry, UK; Queen Elizabeth Hospital-Cancer Centre, Birmingham, UK. · Europa Uomo, Antwerp, Belgium; Bundesverband Prostatakrebs Selbsthilfe, Bonn, Germany. · Greater Manchester Strategic Health Authority, Manchester, UK. · Dept. of Radiation Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, Belgium. · Urologic and Radiation Oncology, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland. · Dept of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Integraal Kankercentrum Nederland (IKNL), Comprehensive Cancer Centre Netherlands, Utrecht, The Netherlands. · Dept of Oncology and Palliative Medicine, Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Dept of Urology, University of Naples Federico II, Naples, Italy. · Dept of Urology, Bonn University Hospital, Bonn, Germany. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK. · Breast Cancer Unit, Institut Gustave Roussy, Villejuif, France. · Dept of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Dept of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Dept of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Research Department of Clinical, Educational and Health Psychology, University College, London, UK. · Deutsche Krebsgesellschaft, German Cancer Society, Berlin, Germany. · Dept of Radiation Oncology, University Hospital Ulm, Ulm, Germany. · Prostate Cancer Programme, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · European School of Oncology, Milan, Italy. · Pubmed 26092320
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. Electronic address: · US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin, TX, USA. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, UK. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, NJ, USA. · ErasmusMC Cancer Institute, Rotterdam, Netherlands. · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · Pubmed 25743937
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
2014
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Hospital Universitario 12 de Octubre, Madrid, Spain. · Rigshospitalet, Copenhagen, Denmark. · National Institute of Oncology, Budapest, Hungary. · McMaster University, Hamilton, ON, Canada. · ICON Cancer Care, Brisbane, QLD, Australia. · University of Montreal, Montreal, QC, Canada. · Center for Oncology, Hospital Sírio-Libanês, São Paulo, Brazil. · OncoCare Cancer Centre, Singapore. · Centro Oncologico Belenus, Cuernavaca, Mexico. · University of Pisa, Pisa, Italy. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Duke Cancer Institute, Durham, NC, USA. · Pubmed 25242048
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 24478320
  • Irish Cancer Society and University College, Dublin, Ireland. Electronic address: · University Hospital del Mar, Barcelona, Spain. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University Hospital Aachen, Aachen, Germany. · San Camillo and Forlanini Hospital, Rome, Italy. · Centre du Cancer et Institut de Recherche Expérimental et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Hospital Clinic de Barcelona, Barcelona, Spain. · University Hospitals Bristol, Bristol, United Kingdom. · Ospedale San Donato, Istituto Toscano Tumori (ITT), Arezzo, Italy. · University Federico II, Napoli, Italy. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States. · St. James's Hospital and Trinity College, Dublin, Ireland. · Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Kantonsspital St. Gallen, St. Gallen, Switzerland. · Tampere University Hospital, Tampere, Finland. · Georges Pompidou European Hospital, Paris, France. · Department of Urology, Academic Medical Center, Amsterdam, The Netherlands. · Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Erasmus University Medical Center, Rotterdam, The Netherlands. · Pubmed 24703899
2013
  • Affiliations of authors: Department of Biostatistics and Bioinformatics, (SH, C-YL, EK), and Alliance Statistics and Data Center (SH), Duke University, Durham, NC · Departments of Medicine and Urology, University of California-San Francisco, San Francisco, CA (EJS) · Division of Medical Oncology, Duke Prostate Center and the Duke Cancer Institute, Durham, NC (AJA) · Departments of Medical Oncology and Urology, Yale University Cancer Center, New Haven, CT (DP) · Department of Medical Oncology, San Camillo and Forlanini Hospital, Rome, Italy (CNS) · Sanofi, Malvern, PA (LS) · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France (SO) · Department of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, Surrey, United Kingdom (JdB) · Urology Department, Tulane Cancer Center, New Orleans, LA (OS). · Pubmed 24136890
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 23152362
  • San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 24206580
2012
  • Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Pubmed 22987973
2011
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 21943975
2009
  • San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 19805692
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 19297314
2008
  • Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Pubmed 18790987
2014
  • From the San Camillo Forlanini Hospital, Rome, Italy; Yale University Cancer Center, New Haven, CT; Center for Cancer Research, National Cancer Institute, Bethesda, MD; The Royal Marsden Hospital, London, United Kingdom. · Pubmed 24857068
Probable:    Miscellaneous institutions in Rome, IT      
2018
  • From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) - both in Illinois · Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.) · the University of Montreal Hospital Center, Montreal (F.S.) · Herlev Hospital, Herlev, Denmark (P.R.) · Carolina Urologic Research Center, Myrtle Beach, SC (N.S.) · State University of Campinas (Unicamp), Campinas, Brazil (U.F.) · Kiev City Clinical Hospital 3, Kiev, Ukraine (P.I.) · Pfizer, San Francisco (E.D., K.M.) · and the Department of Medical Oncology, San Camillo Forlanini Hospital, Rome (C.N.S.). · Pubmed 29949494
2016
  • Medical Oncology, San Camillo and Forlaninini Hospital, Rome, Italy. Electronic address: · Pubmed 27255585
2008
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 77 total) written by Cora N. Sternberg about Prostatic Neoplasms:

  • The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer. 2018
  • Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer. 2018
  • Enzalutamide in Castration-Resistant Prostate Cancer. 2018
  • Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. 2017
  • A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy. 2017
  • Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial. 2017
  • Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post Hoc Analysis of the Mainsail Study. 2017
  • Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer. 2017
  • Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study. 2017
  • Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL. 2017
Show List of Full Article Records
Google Searches

Learn more about Cora N. Sternberg using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
San Camillo-Foranini Hospitals
Miscellaneous institutions in Rome, IT
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
San Camillo-Foranini Hospitals
2018
  • Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy. · Radboud University Medical Centre, Nijmegen, Netherlands. · Amgen (Europe) GmbH, Zug, Switzerland. · Service d'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. Electronic address: · Pubmed 29787892
  • Robert H. Lurie Comprehensive Cancer Center, Chicago, IL · University of Montreal Hospital Center, Montreal, QC, Canada · San Camillo Forlanini Hospital, Rome, Italy · Pubmed 30281993
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · National Cancer Institute, Vilnius, Lithuania. · Department of Oncology, Herlev Hospital, Herlev. · Department of Oncology, Aalborg University Hospital, Aalborg, Denmark. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon. · INSERM, UMR1098, Besançon. · Medicine, Centre Léon Bérard, Lyon, France. · Department of Oncology & Hematology, Azienda University Hospital, Modena, Italy. · Dana-Farber/Brigham and Women's Cancer Center, Boston, USA. · Department of Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Department of General Medical Oncology, University Hospitals Leuven, Leuven. · KU Leuven, Leuven, Belgium. · Urocentrum, Prague, Czech Republic. · General Oncology Department, Centre Oscar Lambret, Lille, France. · Lithuanian University of Health Sciences Hospital, Kaunas, Lithuania. · Gabinet Urologiczny, Gdynia, Gdansk, Poland. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Ipsen Innovation, Les Ulis, France. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Pubmed 29059273
  • OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Electronic address: · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Cancer Medicine, Gustave Roussy, University of Paris-Sud, Villejuif, France. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium. · Department of Medical Oncology, Vall d'Hebron University Hospital, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medicine, University of Colorado School of Medicine, Aurora, CO. · Department of Medical Oncology, USC Norris Cancer Hospital, Keck Medical Center of USC, Los Angeles, CA. · Department of Biostatistics, Astellas Pharma Europe, BV, Leiden, Netherlands. · Department of Biostatistics, Medivation, Inc, San Francisco, CA. · Department of Clinical Development, Medivation, Inc, San Francisco, CA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 28344102
  • Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands. · US Oncology Research, Houston, Texas3Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Yale Cancer Center, Division of Oncology, Department of Medicine, New Haven, Connecticut. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin. · University Hospital del Mar-IMIM, Barcelona, Spain10Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · US Oncology Research, Houston, Texas11Rocky Mountain Cancer Centers, Aurora, Colorado. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, England. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare " Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, England. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, New Jersey. · Pubmed 27560549
  • US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. Electronic address: · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA. · Oncology Hematology Care, Inc., Cincinnati, OH, USA. · US Oncology, Cancer Centers of North Carolina, Raleigh, NC, USA. · Texas Oncology, Austin, TX, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Department of Uro-Oncology, Centrum Onkologii - Instytut im Marii Sklodowskiej-Curie, Warsaw, Poland. · Celgene Corporation, Summit, NJ, USA. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. · Pubmed 27522164
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Clinical Medicine, Rigshospitalet, Copenhagen, Denmark. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Medical Oncology, Astellas Pharma, Inc., Northbrook, IL, USA. · Biostatistics, Astellas Pharma, Inc., Northbrook, IL, USA. · Pubmed 28117385
2016
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Padiglione Flajani, Circonvallazione Gianicolense 87, Rome, 00152, Italy. Electronic address: · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Padiglione Flajani, Circonvallazione Gianicolense 87, Rome, 00152, Italy. Electronic address: · Pubmed 27637350
  • Department of Molecular and Translational Medicine, University of Brescia, 25123, Brescia, Italy; Molecular Therapy and Pharmacogenomic Unit, ASST di Cremona, Viale Concordia 1, 26100, Cremona, Italy. Electronic address: · Department of Molecular and Translational Medicine, University of Brescia, 25123, Brescia, Italy. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Radiotherapy Department, Azienda Ospedaliera "Istituti Ospitalieri di Cremona", Cremona, Italy. · Molecular Therapy and Pharmacogenomic Unit, ASST di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Medical Oncology Department, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Pathology, Peter Mac Callum Cancer Centre, and Department of Pathology, University of Melbourne, Australia. · Molecular Therapy and Pharmacogenomic Unit, ASST di Cremona, Viale Concordia 1, 26100, Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, 34129, Trieste, Italy. · Pubmed 27162152
  • Matthew Smith, Massachusetts General Hospital, Boston, MA · Johann De Bono, Royal Marsden Hospital, Sutton · Syed Hussain, University of Liverpool, Liverpool, United Kingdom · Cora Sternberg, San Camillo and Forlanini Hospitals, Rome · Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola · Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy · Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce · Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris · Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon · Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes · Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France · Michael Krainer, Medical University of Vienna, Vienna, Austria · Andries Bergman, Netherlands Cancer Institute, Amsterdam · Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands · Wolfgang Hoelzer, Praxis für Urologie · Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin · Martin Bögemann, University of Muenster Medical Center, Muenster · Susan Feyerabend, Studienpraxis Urologie, Nürtingen · Arnulf Stenzl, University Hospital, Tübingen, Germany · Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada · Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO · Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego · David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA · and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
  • Cora Sternberg, San Camillo Forlanini Hospitals, Rome, Italy · Andrew Armstrong, Duke Cancer Institute, Duke University, Durham, NC · Roberto Pili, Indiana University School of Medicine, Indianapolis, IN · Siobhan Ng, St John of God Medical Centre, Subiaco, Western Australia, Australia · Robert Huddart, Royal Marsden Hospital, Sutton · Nicholas James, Queen Elizabeth Hospital, Birmingham · Simon Chowdhury, Guy's Hospital and Sarah Cannon Research UK, London, United Kingdom · Neeraj Agarwal, University of Utah, Salt Lake City, UT · Denis Khvorostenko, Leningrad Regional Oncology Dispensary, St Petersburg, Russia · Olexiy Lyulko, Zaporizhzhya Regional Clinical Hospital, Zaporizhzhya, Ukraine · Arija Brize, Riga Eastern Clinical University Hospital, Riga, Latvia · Nicholas Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Rémy Delva, Centre Régional de Lutte Contre le Cancer Paul Papin, Angers · Jean-Christophe Pouget and Frédérique Baton, Ipsen Innovation, Les Ulis, France · Mihai Harza, Fundeni Clinical Institute, Bucharest, Romania · Anastasios Thanos, Agios Savas Anticancer Oncology Hospital of Athens, Athens, Greece · Patrick Werbrouck, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium · Martin Bögemann, Universitätsklinikum Münster, Münster, Germany · Thomas Hutson, Texas Oncology, Dallas, TX · Piotr Milecki, Poznan University of Medical Sciences, Poznan, Poland · Enrique Gallardo, Corporació Sanitaria Parc Taulí, Sabadell, Spain · Gilberto Schwartsmann, Hospital De Clinicas De Porto Alegre, Porto Alegre, Brazil · Thore Nederman and Helen Tuvesson, Active Biotech, Lund, Sweden · and Michael Carducci, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD. · Pubmed 27298414
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland Division of Oncology, Portland VA Medical Center, Portland, USA · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Divisions of Medical Oncology and Urology, Duke University Medical Center and the Duke Cancer Institute, Durham. · Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, USA. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, København, Denmark. · Department of Medical Oncology, University of Colorado Cancer Center, Aurora. · Medivation, Inc., San Francisco, USA. · Astellas Pharma Global Development, Inc., Leiden, The Netherlands. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 26578735
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Pubmed 27302137
  • Department of Medical Physics, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Department of Nuclear Medicine, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Health Physics Postgraduate School, "Sapienza" University of Rome, Piazzale Aldo Moro No. 5, 00185, Rome, Italy. · Department of Radiology, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Health Physics Postgraduate School, "Sapienza" University of Rome, Piazzale Aldo Moro No. 5, 00185, Rome, Italy. · Department of Radiological, Oncological and Anatomo Pathological Sciences, "Sapienza" University of Rome, Viale Del Policlinico No. 155, 00161, Rome, Italy. · Department of Medical Oncology, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Department of Medical Oncology, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Department of Nuclear Medicine, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense No. 87, 00152, Rome, Italy. · Pubmed 26613714
  • Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 26659397
2015
  • Medical Oncology Department, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Medical Oncology Department, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 26170619
  • European School of Oncology, Milan, Italy; Prostate Cancer Programme, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Dept of Urology, University Hospital of the Katholieke Universiteit Leuven, Leuven, Belgium. · Renal Cancer Services, Royal Free Hospital, London, UK. · Dept of Urology, Heinrich Heine University Hospital, Düsseldorf, Germany. · Centre Polidisciplinaire d'Oncologie, Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Dept of Radiation Oncology, Institut Gustave Roussy, Villejuif, France. · Dept of Urology, Ausl Modena, Nuovo Ospedale Civile-S. Agostino Estense, Modena, Italy. · Europa Uomo, Antwerp, Belgium; Oncological Centre, Antwerp, Belgium. · King's College Hospital NHS Foundation Trust, London, UK. · University of Warwick, Cancer Research Unit, Coventry, UK; Queen Elizabeth Hospital-Cancer Centre, Birmingham, UK. · Europa Uomo, Antwerp, Belgium; Bundesverband Prostatakrebs Selbsthilfe, Bonn, Germany. · Greater Manchester Strategic Health Authority, Manchester, UK. · Dept. of Radiation Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, Belgium. · Urologic and Radiation Oncology, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland. · Dept of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Integraal Kankercentrum Nederland (IKNL), Comprehensive Cancer Centre Netherlands, Utrecht, The Netherlands. · Dept of Oncology and Palliative Medicine, Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Dept of Urology, University of Naples Federico II, Naples, Italy. · Dept of Urology, Bonn University Hospital, Bonn, Germany. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK. · Breast Cancer Unit, Institut Gustave Roussy, Villejuif, France. · Dept of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Dept of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Dept of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Research Department of Clinical, Educational and Health Psychology, University College, London, UK. · Deutsche Krebsgesellschaft, German Cancer Society, Berlin, Germany. · Dept of Radiation Oncology, University Hospital Ulm, Ulm, Germany. · Prostate Cancer Programme, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · European School of Oncology, Milan, Italy. · Pubmed 26092320
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. Electronic address: · US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin, TX, USA. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, UK. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, NJ, USA. · ErasmusMC Cancer Institute, Rotterdam, Netherlands. · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · Pubmed 25743937
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
2014
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Hospital Universitario 12 de Octubre, Madrid, Spain. · Rigshospitalet, Copenhagen, Denmark. · National Institute of Oncology, Budapest, Hungary. · McMaster University, Hamilton, ON, Canada. · ICON Cancer Care, Brisbane, QLD, Australia. · University of Montreal, Montreal, QC, Canada. · Center for Oncology, Hospital Sírio-Libanês, São Paulo, Brazil. · OncoCare Cancer Centre, Singapore. · Centro Oncologico Belenus, Cuernavaca, Mexico. · University of Pisa, Pisa, Italy. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Duke Cancer Institute, Durham, NC, USA. · Pubmed 25242048
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 24478320
  • Irish Cancer Society and University College, Dublin, Ireland. Electronic address: · University Hospital del Mar, Barcelona, Spain. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University Hospital Aachen, Aachen, Germany. · San Camillo and Forlanini Hospital, Rome, Italy. · Centre du Cancer et Institut de Recherche Expérimental et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Hospital Clinic de Barcelona, Barcelona, Spain. · University Hospitals Bristol, Bristol, United Kingdom. · Ospedale San Donato, Istituto Toscano Tumori (ITT), Arezzo, Italy. · University Federico II, Napoli, Italy. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States. · St. James's Hospital and Trinity College, Dublin, Ireland. · Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Kantonsspital St. Gallen, St. Gallen, Switzerland. · Tampere University Hospital, Tampere, Finland. · Georges Pompidou European Hospital, Paris, France. · Department of Urology, Academic Medical Center, Amsterdam, The Netherlands. · Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Erasmus University Medical Center, Rotterdam, The Netherlands. · Pubmed 24703899
2013
  • Affiliations of authors: Department of Biostatistics and Bioinformatics, (SH, C-YL, EK), and Alliance Statistics and Data Center (SH), Duke University, Durham, NC · Departments of Medicine and Urology, University of California-San Francisco, San Francisco, CA (EJS) · Division of Medical Oncology, Duke Prostate Center and the Duke Cancer Institute, Durham, NC (AJA) · Departments of Medical Oncology and Urology, Yale University Cancer Center, New Haven, CT (DP) · Department of Medical Oncology, San Camillo and Forlanini Hospital, Rome, Italy (CNS) · Sanofi, Malvern, PA (LS) · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France (SO) · Department of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, Surrey, United Kingdom (JdB) · Urology Department, Tulane Cancer Center, New Orleans, LA (OS). · Pubmed 24136890
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 23152362
  • San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 24206580
2012
  • Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Pubmed 22987973
2011
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 21943975
2009
  • San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 19805692
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Pubmed 19297314
2008
  • Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Pubmed 18790987
2014
  • From the San Camillo Forlanini Hospital, Rome, Italy; Yale University Cancer Center, New Haven, CT; Center for Cancer Research, National Cancer Institute, Bethesda, MD; The Royal Marsden Hospital, London, United Kingdom. · Pubmed 24857068
Miscellaneous institutions in Rome, IT
2018
  • From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) - both in Illinois · Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.) · the University of Montreal Hospital Center, Montreal (F.S.) · Herlev Hospital, Herlev, Denmark (P.R.) · Carolina Urologic Research Center, Myrtle Beach, SC (N.S.) · State University of Campinas (Unicamp), Campinas, Brazil (U.F.) · Kiev City Clinical Hospital 3, Kiev, Ukraine (P.I.) · Pfizer, San Francisco (E.D., K.M.) · and the Department of Medical Oncology, San Camillo Forlanini Hospital, Rome (C.N.S.). · Pubmed 29949494
2016
  • Medical Oncology, San Camillo and Forlaninini Hospital, Rome, Italy. Electronic address: · Pubmed 27255585
2008
48 Other Locations Show
Yearly article counts 371177778776
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.